lyphomed inc said and vestar inc entered into joint venture develop and market liposome formulations selected drugs liposomes spheres subcellular size which composed phospholipids primary components living cell membranes during project first year companies will jointly develop liposome formulations for designated drugs and establish commercial production capacity well coordinate and fund clinical studies formulations reuter 